Literature DB >> 24819978

[Non-seminomatous germ cell tumours].

F Bremmer1, C L Behnes, S Schweyer.   

Abstract

The group of non-seminomatous germ cell tumors can be morphologically and therapeutically distinguished from the group of seminomas. The group of non-seminomatous germ cell tumors includes embryonal carcinoma, yolk sac tumor, choriocarcinoma and teratoma. All entities can occur rarely in pure form or much more commonly in mixed germ cell tumors consisting of more than one histological type. The non-seminomatous germ cell tumors are also characterized by the appearance of an isochromosome 12p, i(12p) and arise from a common precursor lesion called intratubular germ cell neoplasia of the unclassified type (ITGCNU). Various immunohistochemical markers are used to distinguish the different tumor components in addition to morphological characteristics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24819978     DOI: 10.1007/s00292-014-1900-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  23 in total

1.  Oncofetal protein glypican-3 in testicular germ-cell tumor.

Authors:  Satoshi Ota; Michiyo Hishinuma; Naoko Yamauchi; Akiteru Goto; Teppei Morikawa; Tetsuya Fujimura; Tadaichi Kitamura; Tatsuhiko Kodama; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Virchows Arch       Date:  2006-08-04       Impact factor: 4.064

2.  Developments in histopathology of testicular germ cell tumors.

Authors:  F K Mostofi; I A Sesterhenn; C J Davis
Journal:  Semin Urol       Date:  1988-08

3.  Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.

Authors:  A Heidenreich; I A Sesterhenn; F K Mostofi; J W Moul
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

4.  Epidemiological and clinical behavior of prepubertal testicular tumors in Korea.

Authors:  Sang Don Lee
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

5.  Ber-H2 expression in testicular germ cell tumors.

Authors:  J A Ferreiro
Journal:  Hum Pathol       Date:  1994-05       Impact factor: 3.466

6.  Evidence supporting the existence of benign teratomas of the postpubertal testis: a clinical, histopathologic, and molecular genetic analysis of 25 cases.

Authors:  Chen Zhang; Daniel M Berney; Michelle S Hirsch; Liang Cheng; Thomas M Ulbright
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

7.  Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases.

Authors:  G Krag Jacobsen; H Barlebo; J Olsen; H P Schultz; H Starklint; H Søgaard; M Vaeth
Journal:  Acta Radiol Oncol       Date:  1984

8.  OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.

Authors:  Timothy D Jones; Thomas M Ulbright; John N Eble; Lee Ann Baldridge; Liang Cheng
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

9.  Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP.

Authors:  A Talerman; W G Haije; L Baggerman
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

10.  Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the Prepubertal Testis Tumor Registry.

Authors:  Jonathan H Ross; Lisa Rybicki; Robert Kay
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  2 in total

1.  [Germ cell and sex cord-stromal tumors of the testis : WHO classification 2016].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

2.  Successful radiotherapy in postoperative recurrence of a primary mediastinal yolk sac tumor: A case report.

Authors:  Masakuni Sakaguchi; Toshiya Maebayashi; Takuya Aizawa; Naoya Ishibashi; Shoko Fukushima; Tsutomu Saito
Journal:  Thorac Cancer       Date:  2015-08-20       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.